Literature DB >> 29848052

Low frequency electromagnetic field decreases ischemia-reperfusion injury of human cardiomyocytes and supports their metabolic function.

Dariusz Biały1, Magdalena Wawrzyńska2, Iwona Bil-Lula3, Anna Krzywonos-Zawadzka3, Agnieszka Sapa-Wojciechowska3, Jacek Arkowski2, Mieczysław Woźniak3,4, Grzegorz Sawicki3,4.   

Abstract

Electromagnetic field at extremely low frequencies plays a significant role in the physiological function of human tissues and systems. It is shown that electromagnetic field inhibits production of reactive oxygen species which are involved in heart injury triggered by oxidative stress. We hypothesize that low frequency electromagnetic field protects function of cardiac cells from ischemia-reperfusion injury. Human cardiac myocytes, endothelial cells, and cardiac fibroblast underwent ischemia-reperfusion conditions in the presence or in the absence of low frequency electromagnetic field. LDH and MMP-2 activities (as markers of cell injury), and cell metabolic activity (by fluorescein diacetate staining) were measured to determine the protective role of low frequency electromagnetic field. Our data showed that short courses of low frequency electromagnetic field protect cardiac cells from cellular damage and preserve their metabolic activity during ischemia-reperfusion. This study demonstrates the possibility to use of low frequency electromagnetic field as strategy for the prevention or therapy of ischemia-reperfusion injury. Impact statement In our study, we showed that LF-EMF may be protective for heart during ischemia-reperfusion (I/R). Following is the short description of the main findings: (a) the response to the I/R injury was different for endothelial cells, fibroblasts, and cardiomyocytes; (b) I/R decreases MMP-2 activity in cardiac myocytes and fibroblasts; (c) I/R increases MMP-2 activity in endothelial cells; (d) LF-EMF reverses these changes; (e) LF-EMF protects cells from injury and preserves their metabolic activity.

Entities:  

Keywords:  Low frequency electromagnetic field; cardiomyocytes; cardioprotection; endothelium; fibroblasts

Mesh:

Substances:

Year:  2018        PMID: 29848052      PMCID: PMC6022916          DOI: 10.1177/1535370218779773

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  44 in total

Review 1.  Extracellular matrix remodelling: the role of matrix metalloproteinases.

Authors:  Ivan Stamenkovic
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

2.  Neonatal asphyxia induces the nitration of cardiac myosin light chain 2 that is associated with cardiac systolic dysfunction.

Authors:  Adrian Doroszko; Dorota Polewicz; Virgilio J J Cadete; Jolanta Sawicka; Michelle Jones; Danuta Szczesna-Cordary; Po-Yin Cheung; Grzegorz Sawicki
Journal:  Shock       Date:  2010-12       Impact factor: 3.454

Review 3.  Structural and functional coupling of cardiac myocytes and fibroblasts.

Authors:  Patrizia Camelliti; Colin R Green; Peter Kohl
Journal:  Adv Cardiol       Date:  2006

4.  Effects of extremely low frequency magnetic field on the parameters of oxidative stress in heart.

Authors:  A Goraca; E Ciejka; A Piechota
Journal:  J Physiol Pharmacol       Date:  2010-06       Impact factor: 3.011

Review 5.  Cardiac sarcomeric proteins: novel intracellular targets of matrix metalloproteinase-2 in heart disease.

Authors:  Mohammad A M Ali; Xiaohu Fan; Richard Schulz
Journal:  Trends Cardiovasc Med       Date:  2011-05       Impact factor: 6.677

6.  Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.

Authors:  Márton Jani; Hedvig Tordai; Mária Trexler; László Bányai; László Patthy
Journal:  Biochimie       Date:  2005 Mar-Apr       Impact factor: 4.079

Review 7.  Free radicals and antioxidants in cardiovascular disease.

Authors:  S R Maxwell; G Y Lip
Journal:  Br J Clin Pharmacol       Date:  1997-10       Impact factor: 4.335

8.  Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.

Authors:  F G Spinale; M L Coker; C V Thomas; J D Walker; R Mukherjee; L Hebbar
Journal:  Circ Res       Date:  1998-03-09       Impact factor: 17.367

9.  Heart protection by ischemic preconditioning: a novel pathway initiated by iron and mediated by ferritin.

Authors:  Mordechai Chevion; Shirley Leibowitz; Nu Nu Aye; Odeya Novogrodsky; Adar Singer; Oded Avizemer; Baruch Bulvik; Abraham M Konijn; Eduard Berenshtein
Journal:  J Mol Cell Cardiol       Date:  2008-09-10       Impact factor: 5.000

Review 10.  Mitochondrial complex III regulates hypoxic activation of HIF.

Authors:  T Klimova; N S Chandel
Journal:  Cell Death Differ       Date:  2008-01-25       Impact factor: 15.828

View more
  3 in total

1.  Tissue Expression of Atrial and Ventricular Myosin Light Chains in the Mechanism of Adaptation to Oxidative Stress.

Authors:  Marta Banaszkiewicz; Anna Krzywonos-Zawadzka; Agnieszka Olejnik; Iwona Bil-Lula
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

2.  Expression of atrial‑fetal light chains in cultured human cardiomyocytes after chemical ischemia‑reperfusion injury.

Authors:  Marta Banaszkiewicz; Agnieszka Olejnik; Anna Krzywonos-Zawadzka; Kornela Hałucha; Iwona Bil-Lula
Journal:  Mol Med Rep       Date:  2021-09-07       Impact factor: 2.952

3.  Silencing RNA for MMPs May Be Utilized for Cardioprotection.

Authors:  Marta Banaszkiewicz; Anna Krzywonos-Zawadzka; Agnieszka Olejnik; Agnieszka Noszczyk-Nowak; Iwona Bil-Lula
Journal:  Cardiovasc Ther       Date:  2022-08-24       Impact factor: 3.368

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.